Small Pharma Inc V.DMT

Healthcare

Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.

TSXV:DMT - Post by User

Small Pharma Inc > Continued Insider Buying

<< Previous

Bullboard Posts

Next >>

Post by GillRipperon Sep 05, 2022 9:25am

112 Views

Post# 34941957

Continued Insider Buying

Date	Issuer	Insider	Transaction	Amount	New Balance
Recent filings
Filed 2022-09-03 10:59 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,008 +3,000 vol $0.336 each	78,336,943
Filed 2022-09-03 10:59 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$335.00 +1,000 vol $0.335 each	78,333,943
Filed 2022-09-03 10:58 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$165.00 +500 vol $0.33 each	78,332,943
Filed 2022-09-03 10:58 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$325.00 +1,000 vol $0.325 each	78,332,443
Filed 2022-09-03 10:57 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$800.00 +2,500 vol $0.32 each	78,331,443
Filed 2022-09-03 10:57 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,040 +10,000 vol $0.304 each	78,328,943
Filed 2022-09-03 10:56 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$930.00 +3,000 vol $0.31 each	78,318,943
Filed 2022-09-03 10:55 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,150 +10,500 vol $0.30 each	78,315,943
Filed 2022-09-03 10:55 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,475 +5,000 vol $0.295 each	78,305,443
Filed 2022-09-03 10:54 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,560 +20,000 vol $0.278 each	78,300,443
Filed 2022-09-03 10:54 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,375 +5,000 vol $0.275 each	78,280,443
Filed 2022-09-03 10:53 Tx date 2022-08-31	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,325 +5,000 vol $0.265 each	78,275,443
Filed 2022-09-03 10:51 Tx date 2022-08-30	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,225 +5,000 vol $0.245 each	78,270,443
Filed 2022-09-03 10:51 Tx date 2022-08-30	$DMT Small Pharma Inc. (formerly, Unilock Capital Corp.)	Rands, Peter David 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$9,600 +40,000 vol $0.24 each	78,265,443